Alfuzosin hydrochloride

• Catalog No.: A0232
• CAS Number: 81403-68-1
• M. F.: C19H28ClN5O4
• M. W.: 425.90972
• Purity: ≥98% (HPLC)

SYNONYMS

• IUPAC name: N-{3-[(4-amino-6,7-dimethoxyquinazolin-2-yl)(methyl)amino]propyl}oxolane-2-carboxamide hydrochloride
• IUPAC Traditional name: alfuzosin hydrochloride
• Synonyms: Uroxatral hydrochloride; N-(3-((4-Amino-6,7-dimethoxy-2-quinazolinyl)methylamino)propyl)tetrahydro-2-furancarboxamide hydrochloride

DATABASE IDS

• CAS Number: 81403-68-1
• MDL Number: MFCD00879135

PROPERTIES

• Empirical Formula (Hill Notation): C19H27N5O4 · HCl
• Purity: ≥98% (HPLC)
• Apperance: solid
• Solubility: DMSO: >10 mg/mL
• Solubility: H2O: insoluble
• GHS Signal Word: Warning
• GHS Hazard statements: H302
• European Hazard Symbols: Harmful (Xn)
• Personal Protective Equipment: dust mask type N95 (US), Eyeshields, Gloves
• Risk Statements: 22
• German water hazard class: 3

DETAILS

Description (English)

Biochem/physiol Actions
Alfuzosin hydrochloride is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.

Description (简体中文)

Biochem/physiol Actions
Alfuzosin hydrochloride is an alpha-adrenergic blocker used to treat benign prostatic hyperplasia (BPH). It works by relaxing the muscles in the prostate and bladder neck, making it easier to urinate.